Original articleBronchospasm caused by intravenous Hydrocortisone sodium succinate (cas 125-04-2) (Solu-Cortef) in aspirin-sensitive asthmatics
-
Add time:10/01/2019 Source:sciencedirect.com
Eleven patients with intrinsic asthma and aspirin sensitivity were challenged with intravenous Hydrocortisone sodium succinate (cas 125-04-2) (Solu-Cortef; the Upjohn Co., Kalamazoo, Mich.). Three patients showed definite evidence of bronchospasm, which was easily reversed by subcutaneous administration of epinephrine. Evidence is presented which suggests that this reaction was not caused by other constituents of the preparation but rather was caused by Solu-Cortef alone. No atopy was demonstrated in the group as a whole, and the reaction observed was probably nonallergic in nature. We suggest the replacement of intravenous hydrocortisone sodium succinate with dexamethasone in the treatment of such a population.
We also recommend Trading Suppliers and Manufacturers of Hydrocortisone sodium succinate (cas 125-04-2). Pls Click Website Link as below: cas 125-04-2 suppliers
Prev:Effect of chronic hypocortisolaemia on plasma cortisol concentrations during intravenous infusions of Hydrocortisone sodium succinate (cas 125-04-2) in dogs
Next:Original StudyResults of a Real-world Study of Enzalutamide and Abiraterone Acetate with Prednisone Tolerability (REAAcT)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effect of chronic hypocortisolaemia on plasma cortisol concentrations during intravenous infusions of Hydrocortisone sodium succinate (cas 125-04-2) in dogs09/27/2019
- Perioperative hydrocortisone treatment reduces postoperative pancreatic fistula rate after open distal pancreatectomy. A randomized placebo-controlled trial09/26/2019
- Original articleMolecular and cytogenetic evaluation for potential genotoxicity of hydrocortisone09/25/2019
- Short CommunicationHydrocortisone relieves the immediate post-operative scrotal edema after inguinal varicocelectomy: A prospective clinical trial09/24/2019
- Hydrocortisone sodium succinate (cas 125-04-2) does not cross-react with aspirin in aspirin-sensitive patients with asthma☆☆☆★09/10/2019
- Controlled intraoral delivery of Hydrocortisone sodium succinate (cas 125-04-2)09/09/2019
- Short communicationShelf lives of aseptically prepared medicines – stability of Hydrocortisone sodium succinate (cas 125-04-2) in PVC and non-PVC bags and in polypropylene syringes09/08/2019
-
Health and Chemical more >
-
Related Products
- Hydrocortisone 21-hemisuccinate
- Hydrocortisone acetate
- Hydrocortisone buteprate
- Hydrocortisone sodium phosphate
- Hydrocortisone sodium succinate
- Sodium 2,4-dimethylbenzenesulfonate
- SODIUM γ-FLUORO-β-HYDROXYBUTYRATE
- Sodium ((3-methoxy-1-methyl-3-oxo-1-propenyl)amino)phenylacetate
- Sodium (+)-10-camphorsulfonate
- Sodium (2-carbamoylphenoxy)acetate